A 16-year-old patient was treated for leukemia and after chemotherapy developed fever, myalgia, myocardial dysfunction, and athralgia. Blood culture showed Candida tropicalis. Contrast-enhanced computed tomography showed multiple kidney and spleen abscesses. After antifungal therapy (TRIFLUCAN) and before restarting chemotherapy, 18 F-FDG PET/CT was performed [1] , which demonstrated multiple high metabolic activity lesions in the spleen and kidneys, and unknown disseminated lesions in muscles, myocardium, the right lung, and liver [2, 3] . Bonemarrow-increased metabolic activity seems to be related to the recent chemotherapy treatment. Clinical and 18 F-FDG PET/CT evolution was successful after a new antifungal therapy (NOXAFIL).
This case illustrates the usefulness of 18 F-FDG PET/CT in the identification of disseminated candidiasis sites and in the evaluation of antifungal treatment [4] .
